Ye Cheng

3.1k total citations · 2 hit papers
59 papers, 2.1k citations indexed

About

Ye Cheng is a scholar working on Molecular Biology, Cancer Research and Epidemiology. According to data from OpenAlex, Ye Cheng has authored 59 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 15 papers in Cancer Research and 11 papers in Epidemiology. Recurrent topics in Ye Cheng's work include Adipokines, Inflammation, and Metabolic Diseases (7 papers), Cancer-related molecular mechanisms research (6 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (6 papers). Ye Cheng is often cited by papers focused on Adipokines, Inflammation, and Metabolic Diseases (7 papers), Cancer-related molecular mechanisms research (6 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (6 papers). Ye Cheng collaborates with scholars based in China, Germany and Bangladesh. Ye Cheng's co-authors include Weiwei Tang, Fan Wu, Qian Wang, Dawei Rong, Wenling Zhang, Xuehao Wang, Betty Zhang, Ziyi Chen, Florian P. Reiter and Enrico N. De Toni and has published in prestigious journals such as Journal of Agricultural and Food Chemistry, International Journal of Molecular Sciences and PLoS Biology.

In The Last Decade

Ye Cheng

54 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The mechanisms of sorafenib resistance in hepatocellular carcinoma: theoretical basis and therapeutic aspects

2020 752 citations Weiwei Tang, Ziyi Chen et al. Signal Transduction and Targeted Therapy profile →
Melatonin-stimulated MSC-derived exosomes improve diabetic wound healing through regulating macrophage M1 and M2 polarization by targeting the PTEN/AKT pathway

2020 395 citations Dong Xie, Longqing Wang et al. Stem Cell Research & Therapy profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ye Cheng China	19	1.2k	650	283	275	262	59	2.1k
Zhaodong Li China	21	1.2k 0.9×	332 0.5×	322 1.1×	218 0.8×	327 1.2×	50	2.4k
Wei Gong China	22	854 0.7×	359 0.6×	227 0.8×	324 1.2×	177 0.7×	35	2.1k
Soumitro Pal United States	26	1.3k 1.0×	473 0.7×	646 2.3×	493 1.8×	277 1.1×	53	2.4k
Kaishan Tao China	31	1.5k 1.2×	921 1.4×	646 2.3×	304 1.1×	194 0.7×	108	2.9k
Yoshinori Otsuki Japan	34	1.6k 1.3×	492 0.8×	368 1.3×	360 1.3×	170 0.6×	110	3.0k
Wen‐Sheng Wu Taiwan	22	1.0k 0.9×	360 0.6×	273 1.0×	181 0.7×	84 0.3×	41	1.8k
Chuan Liu China	28	1.3k 1.0×	603 0.9×	436 1.5×	254 0.9×	253 1.0×	121	2.3k
Kelvin K. Tsai Taiwan	27	1.4k 1.1×	492 0.8×	907 3.2×	307 1.1×	275 1.0×	51	2.6k
Xudong Tang China	21	776 0.6×	520 0.8×	390 1.4×	148 0.5×	179 0.7×	46	1.7k
Oluwaseun Adebayo Bamodu Taiwan	28	1.1k 0.9×	569 0.9×	468 1.7×	196 0.7×	208 0.8×	67	2.0k

Countries citing papers authored by Ye Cheng

Since Specialization

Citations

This map shows the geographic impact of Ye Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ye Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ye Cheng more than expected).

Fields of papers citing papers by Ye Cheng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ye Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ye Cheng. The network helps show where Ye Cheng may publish in the future.

Co-authorship network of co-authors of Ye Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Ye Cheng. A scholar is included among the top collaborators of Ye Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ye Cheng. Ye Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cheng, Ye, et al.. (2026). STING controls glycolysis and histone lactylation to drive macrophage metabolic reprogramming in postoperative ileus. Communications Biology. 9(1).

Deng, Shurong, Yang Wang, Ching-Wen Huang, et al.. (2024). Extracellular ATP activates H2O2 signaling to mitigate cadmium toxicity by restricting Cd2 + entry and triggering the antioxidant system in Arabidopsis. Plant Science. 352. 112362–112362. 1 indexed citations

Cheng, Ye, et al.. (2024). HDL regulates the risk of cardiometabolic and inflammatory-related diseases: Focusing on cholesterol efflux capacity. International Immunopharmacology. 138. 112622–112622. 9 indexed citations

Wang, Jiahong, et al.. (2024). LAPTM4B enhances the stemness of CD133+ liver cancer stem-like cells via WNT/β-catenin signaling. JHEP Reports. 7(4). 101306–101306.

Wang, Meifeng, et al.. (2024). HDAC2 promotes autophagy-associated HCC malignant progression by transcriptionally activating LAPTM4B. Cell Death and Disease. 15(8). 593–593. 10 indexed citations

Lin, Kai‐Hsin, et al.. (2024). Diverse Cytokines Secreted by Adipocyte in Linking Cardio-Metabolic Disorder and SLE. Frontiers in Bioscience-Landmark. 29(11). 373–373.

Cheng, Ye, et al.. (2024). A rare case of intervertebral disc calcification combined with ossification of the posterior longitudinal ligament in a child: a case report and literature review. BMC Musculoskeletal Disorders. 25(1). 118–118. 1 indexed citations

Cheng, Ye, et al.. (2024). Bone Density of Vertebral Bodies and Ossified Masses in Cervical Ossification of the Posterior Longitudinal Ligament: An Imaging Study Based on MRI, CT, and DEXA. Calcified Tissue International. 116(1). 2–2.

Li, Xiao, Liangliang Wu, Zhiying Zheng, et al.. (2022). Tegaserod Maleate Inhibits Breast Cancer Progression and Enhances the Sensitivity of Immunotherapy. Journal of Oncology. 2022. 1–12. 4 indexed citations

10.

Li, Xiao, Guangshun Sun, Liangliang Wu, et al.. (2021). Upregulation of ADAR Promotes Breast Cancer Progression and Serves as a Potential Therapeutic Target. Journal of Oncology. 2021. 1–18. 12 indexed citations

11.

Wu, Fan, Guoqiang Sun, Wubin Zheng, et al.. (2021). circCORO1C promotes the proliferation and metastasis of hepatocellular carcinoma by enhancing the expression of PD‐L1 through NF‐κB pathway. Journal of Clinical Laboratory Analysis. 35(12). e24003–e24003. 17 indexed citations

12.

Rong, Dawei, Guangshun Sun, Fan Wu, et al.. (2021). Epigenetics: Roles and therapeutic implications of non-coding RNA modifications in human cancers. Molecular Therapy — Nucleic Acids. 25. 67–82. 65 indexed citations

13.

Jiang, Lei, et al.. (2021). The Ratio of CD86+/CD163+ Macrophages Predicts Postoperative Recurrence in Stage II-III Colorectal Cancer. Frontiers in Immunology. 12. 724429–724429. 12 indexed citations

14.

Liu, Wei, Jinghuan Huang, Feng Chen, et al.. (2021). MSC-derived small extracellular vesicles overexpressing miR-20a promoted the osteointegration of porous titanium alloy by enhancing osteogenesis via targeting BAMBI. Stem Cell Research & Therapy. 12(1). 348–348. 30 indexed citations

15.

Su, Xin, Ye Cheng, & Dong Chang. (2021). The Important Role of Leptin in Modulating the Risk of Dermatological Diseases. Frontiers in Immunology. 11. 593564–593564. 16 indexed citations

16.

Sun, Guoqiang, Dawei Rong, Zhouxiao Li, et al.. (2021). Role of Small Molecule Targeted Compounds in Cancer: Progress, Opportunities, and Challenges. Frontiers in Cell and Developmental Biology. 9. 694363–694363. 62 indexed citations

17.

Su, Xin, Guoming Zhang, Ye Cheng, & Bin Wang. (2021). New insights into ANGPTL8 in modulating the development of cardio-metabolic disorder diseases. Molecular Biology Reports. 48(4). 3761–3771. 2 indexed citations

18.

Su, Xin, Ye Cheng, & Bin Wang. (2021). ANGPTL8 in cardio-metabolic diseases. Clinica Chimica Acta. 519. 260–266. 5 indexed citations

19.

Tang, Weiwei, Ziyi Chen, Wenling Zhang, et al.. (2020). The mechanisms of sorafenib resistance in hepatocellular carcinoma: theoretical basis and therapeutic aspects. Signal Transduction and Targeted Therapy. 5(1). 87–87. 752 indexed citations breakdown →

20.

Tai, Yang, et al.. (2019). <p>Suppressing growth and invasion of human hepatocellular carcinoma cells by celecoxib through inhibition of cyclooxygenase-2</p>. Cancer Management and Research. Volume 11. 2831–2848. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact